Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against.
Frey
Kirk A
KA
Department of Radiology, Division of Nuclear Medicine, The University of Michigan, Room B1G-412, AGH, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0028 USA. kfrey@umich.edu
D015415:Biomarkers; D003342:Corpus Striatum / Q000000981:diagnostic imaging* / Q000378:metabolism; D018450:Disease Progression; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000378:metabolism; D009419:Nerve Tissue Proteins; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000378:metabolism*; D013378:Substantia Nigra / Q000000981:diagnostic imaging* / Q000378:metabolism; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods; D015899:Tomography, Emission-Computed, Single-Photon / Q000295:instrumentation / Q000379:methods*
D015415:Biomarkers; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D004298:Dopamine